Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) TAK
$18.13
-1.15%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-08-19 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 4 | 4 | 2026-08-12 | View → |
| 6-K | 6-K | 2026-08-06 | View → |
| 6-K | 6-K | 2026-07-30 | View → |
| 6-K | 6-K | 2026-07-09 | View → |
| 6-K | 6-K | 2026-07-08 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
| 4 | FORM 4 | 2026-07-06 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $18.13
- Market Cap
- $58.57 billion
- 52-Week Range
- $12.99 – $18.89
- Average Volume
- 3.87 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.